Immune restoration disease in HIV-infected patients after antiretroviral therapy [7]

Clinical Infectious Diseases

Volumn 32, Issue 2, 2001, Pages 325-326

  French, M A ^a   Price, P ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

DELAYED HYPERSENSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; LETTER; LYMPHOCYTE COUNT; MYCOBACTERIUM AVIUM; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0035245249     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318465     Document Type: Letter

References (12)

1. Immunorestitution disease involving the innate and adaptive response
2. Zidovudine induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients
3. Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine
4. Immune restoration disease after the treatment of immunodeficient HIV-infected patient's with highly active antiretroviral therapy
5. Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy
6. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhlbitors: An "immune restoration disease"?
7. Immune restoration disease in patients on HAART
8. Highly active antiretroviral therapy
9. "Immune restoration disease" following the treatment of immunodeficient HIV-infected patients with potent anti-retroviral therapy
10. Immune restoration with antiretroviral therapies: Implications for clinical management
11. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: Impact of highly active antiretroviral therapy
12. MHC haplotypes affect the expression of opportunistic infections in HIV patients